1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Trifluridine–tipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more therapies

Technology appraisal guidance [TA669] Published date: 27 January 2021

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Documents

A list of downloadable documents created during development.

Expected publication

  • Equality Impact Assessment (Guidance development) PDF 155.83 KB 27 January 2021  

Declaration of interests

  • Register of interests PDF 152.31 KB 27 January 2021  

Final appraisal document

  • Final appraisal document  
  • Final appraisal document PDF 236.45 KB 11 December 2020  
  • Committee papers PDF 1.36 MB 11 December 2020  
  • Public committee slides PDF 379.85 KB 11 December 2020  

Appraisal consultation

  • Appraisal consultation  
  • Committee papers PDF 4.46 MB 30 December 2019  
  • Public committee slides PDF 806.37 KB 30 December 2019  
  • Appraisal consultation document (PDF version) PDF 300.95 KB 30 December 2019  
  • Appraisal consultation document (online commenting)  

Invitation to participate

  • Final stakeholder list PDF 211.93 KB 05 April 2019  
  • Final scope PDF 176.1 KB 05 April 2019  
  • Draft scope and provisional stakeholder list comments table (post-referral) PDF 154.15 KB 05 April 2019  
  • Equality Impact Assessment (Guidance development) PDF 122.49 KB 05 April 2019  

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

  • Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators  
  • Draft scope post referral PDF 317.98 KB 06 February 2019  
  • Draft matrix post referral PDF 300.23 KB 06 February 2019